Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual Disability "SIPEXI"

Recruiting

Phase 3 Results N/A

References

Sources for Trial Information